Connor Appelman, a Maysville, Ky., native, knew from an early age that he wanted to attend medical school just 65 miles down U.S. 68 at the University of Kentucky. As he puts it, he has always bled blue.
“I’m very proud of my home state, and I’ve always wanted to take care of patients in Kentucky,” he said. “That was always the goal growing up, to graduate from the UK College of Medicine. It’s gone by quickly, but it’s been amazing to live out the dream.”
LEXINGTON, Ky. (April 10, 2020) — As the worldwide coronavirus COVID-19 pandemic continues to play out, researchers are among those working to find innovative solutions to help flatten the curve.
One such researcher is Jamie Sturgill, assistant professor in the University of Kentucky College of Medicine Department of Internal Medicine. Sturgill's research focuses heavily on lung disease.
As the worldwide coronavirus COVID-19 pandemic continues to play out, researchers are among those working to find innovative solutions to help flatten the curve.
One such researcher is Jamie Sturgill, assistant professor in the University of Kentucky College of Medicine Department of Internal Medicine. Sturgill's research focuses heavily on lung disease.
Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury and disease-induced inflammation of the brain.
University of Kentucky virologist Rebecca Dutch normally studies the steps of infection for viruses like human metapneumovirus, but she's been looking at the novel coronavirus these days. The chair of UK’s Department of Molecular & Cellular Biochemistry is leading the College of Medicine’s COVID-19 Unified Research Experts (CURE) Alliance team, which brings together faculty expertise from multiple disciplines across the university to focus on advising COVID-19 patient care and clinical trials based on emerging research. Today, she answers some of our questions about COVID-19.
The Department had nine publications listed in PubMed for the month of March 2020.
1: Jin H, Moseley HNB. Robust Moiety Model Selection Using Mass Spectrometry Measured Isotopologues. Metabolites. 2020 Mar 21;10(3). pii: E118. doi: 10.3390/metabo10030118. PubMed PMID: 32245221.
2: Welden JR, Pawluchin A, van Doorn J, Stamm S. Use of Alu Element Containing Minigenes to Analyze Circular RNAs. J Vis Exp. 2020 Mar 10;(157). doi: 10.3791/59760. PubMed PMID: 32225139.
Timothy Ainger, PhD, had just completed a 10-hour clinic day when he pulled out his cellphone to check his messages. There were 74 in total, which was pretty typical because he was involved in group chats with his pals, as well as a Fantasy Football league. However, amid those messages were 14 notifications from his wife, Jan.
Researchers and faculty from multiple disciplines across the University of Kentucky are coming together as part of the global effort to treat, understand and eradicate COVID-19.
The COVID-19 Unified Research Experts (CURE) Alliance team, a new workgroup within UK’s College of Medicine, is bringing together UK experts from across the campus to focus on advising COVID-19 patient care and clinical trials based on emerging research and potential treatment options.
